The drugmaker said it expects that people with private health insurance or coverage through public programs like Medicare or Medicaid will pay nothing.
Pfizer’s two-shot vaccine debuted in late 2020 and has been the most common preventive shot used to fight COVID-19 in the U.S.
That doesn’t count another 12 million doses of an updated booster that was approved earlier this year. The FDA authorized new COVID boosters targeting the Omicron BA.4 and BA.5 subvariants, and Dr. Uché Blackstock says you should expect annual booster shots.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer says COVID-19 vaccine will cost $110 to $130 per dose when feds stop payingPfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free.
Read more »
Pfizer says COVID-19 vaccine will cost $110-$130 per dosePfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free.
Read more »
Pfizer says COVID-19 vaccine will cost $110-$130 per dosePfizer said the commercial pricing for adult COVID-19 vaccine doses could start in early 2023, depending on when the U.S. government phases out its program of buying the shots. FOX13
Read more »
Pfizer says COVID-19 vaccine will cost $110-$130 per dosePfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots. Some will get it for free.
Read more »
Pfizer says COVID-19 vaccine will cost $110-$130 per dosePfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will continue receiving it for free. Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots. The drugmaker said it expects that people with private health insurance or coverage through public programs like Medicare or Medicaid will pay nothing.
Read more »